Cite
HARVARD Citation
Schönberger, S. et al. (2018). Brentuximab vedotin exerts profound antiproliferative and pro‐apoptotic efficacy in CD30‐positive as well as cocultured CD30‐negative germ cell tumour cell lines. Journal of cellular and molecular medicine. 22 (1), pp. 568-575. [Online].